NDATOPICALGEL
Approved
Oct 1984
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
BENZAMYCIN (erythromycin and benzoyl peroxide) by Bausch + Lomb is clinical pharmacology the exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. First approved in 1984.
Drug data last refreshed 9h ago · AI intelligence enriched 6d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Benzamycin is a topical gel combining erythromycin (antibiotic) and benzoyl peroxide (keratolytic) for treatment of acne vulgaris. Erythromycin reduces acne lesions through antibacterial activity, while benzoyl peroxide provides keratolytic and desquamative effects. The combination targets acne through dual mechanisms applied directly to affected skin.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30), indicating transition toward defensive/generic-containment strategies and smaller team focus.
Mechanism of Action
CLINICAL PHARMACOLOGY The exact mechanism by which erythromycin reduces lesions of acne vulgaris is not fully known; however, the effect appears to be due in part to the antibacterial activity of the drug. Benzoyl peroxide has a keratolytic and desquamative effect which may also contribute to its…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Zero linked job openings reflect the product's mature, declining phase with minimal growth headcount needs. Career opportunities on Benzamycin are limited to maintenance roles managing existing market presence rather than expansion or innovation.
Brand Manager
Worked on BENZAMYCIN at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.